gliclazide has been researched along with Acute Generalised Exanthematous Pustulosis in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contreras-Steyls, M | 1 |
| Vílchez-Márquez, F | 1 |
| Mota, A | 1 |
| Moyano, B | 1 |
| Herrera-Ceballos, E | 1 |
1 other study available for gliclazide and Acute Generalised Exanthematous Pustulosis
| Article | Year |
|---|---|
Acute generalized exanthematous pustulosis induced by gliclazide: a case report.
Topics: Acute Generalized Exanthematous Pustulosis; Aged; Diabetes Mellitus, Type 2; Female; Gliclazide; Hum | 2013 |